Williams beats first quarter profit estimates, says CEO to step down-February 2024-www.financetom.com

Williams beats first quarter profit estimates, says CEO to step down

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Williams beats first quarter profit estimates, says CEO to step down

May 26, 2025 1:32 AM

May 5 (Reuters) - U.S. pipeline operator Williams

beat first-quarter profit estimates on Monday, and said

Alan Armstrong will step down as the chief executive officer,

effective July 1.

The company posted an adjusted profit of 60 cents per share

for the quarter ended March 31, compared with average analysts'

estimate of 56 cents per share, according to data compiled by

LSEG.

Previous page： Firms launch physical uranium buying for small investors using blockchain Next page： Corbus Pharmaceuticals' CRB-701 Gets FDA Fast Track Designation for Treatment of Cervical Cancer

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Firms launch physical uranium buying for small investors using blockchain

Dec 3, 2024

LONDON, Dec 3 (Reuters) - A blockchain platform and a uranium trading company launched a marketplace on Tuesday to allow small investors to buy physical uranium, hoping to boost spot liquidity in the niche commodity. Uranium has seen a surge in interest from investors and a spike in prices in recent years as miners trimmed output and utilities sought new...

Corbus Pharmaceuticals' CRB-701 Gets FDA Fast Track Designation for Treatment of Cervical Cancer

Dec 3, 2024

08:59 AM EST, 12/03/2024 (MT Newswires) -- Corbus Pharmaceuticals Holdings ( CRBP ) said Tuesday that CRB-701 has received fast track designation from the US Food and Drug Administration for the treatment of relapsed or refractory metastatic cervical cancer. The company said the designation aims to facilitate the development and hasten the review of drugs that have the potential to...

PTC Collaborates With Microsoft, Volkswagen to Add Generative AI to Codebeamer

Dec 3, 2024

09:01 AM EST, 12/03/2024 (MT Newswires) -- PTC (PTC) said Tuesday it partnered with Microsoft ( MSFT ) and Volkswagen Group to add generative AI to its software engineering product Codebeamer. Microsoft ( MSFT ) will embed the capabilities of its virtual AI assistant Copilot into PTC's Codebeamer, which Volkswagen has been using for software development across its brands and...

BRIEF-Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries

Dec 3, 2024

Dec 3 (Reuters) - Coeptis Therapeutics Holdings Inc ( COEP ) : * COEPTIS THERAPEUTICS EXECUTES BINDING LETTER OF INTENT TO ACQUIRE AI-POWERED MARKETING SOLUTIONS FOR BIOTECH, PHARMACEUTICAL AND OTHER INDUSTRIES Source text: Further company coverage: ...